Literature DB >> 32194198

Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life.

Ravi B Patel1, Laura A Colangelo2, Alexander P Reiner3, Myron D Gross4, David R Jacobs5, Lenore J Launer6, Joao A C Lima7, Donald M Lloyd-Jones8, Sanjiv J Shah9.   

Abstract

BACKGROUND: E-selectin and intercellular adhesion molecule (ICAM)-1 are biomarkers of endothelial activation, which has been implicated in the pathogenesis of heart failure (HF) with preserved ejection fraction (HFpEF). However, the temporal associations between E-selectin and ICAM-1 with subclinical cardiac dysfunction are unclear.
OBJECTIVES: This study sought to assess the longitudinal associations of E-selectin and ICAM-1 with subclinical alterations in cardiac function.
METHODS: In the Coronary Artery Disease Risk Development in Young Adults study, a cohort of black and white young adults, we evaluated the associations of E-selectin and ICAM-1, obtained at year (Y) 7 (Y7) and Y15 examinations, with cardiac function assessed at Y30 after adjustment for key covariates.
RESULTS: Higher E-selectin (n = 1,810) and ICAM-1 (n = 1,548) at Y7 were associated with black race, smoking, hypertension, and higher body mass index. After multivariable adjustment, higher E-selectin at Y7 (β coefficient per 1 SD higher: 0.22; SE: 0.06; p < 0.001) and Y15 (β coefficient per 1 SD higher: 0.19; SE: 0.06; p = 0.002) was associated with worse left ventricular (LV) global longitudinal strain (GLS). Additionally, higher Y15 ICAM-1 (β coefficient per 1 SD higher: 0.18; SE: 0.06; p = 0.004) and its increase from Y7 to Y15 (β coefficient per 1 SD higher: 0.16; SE: 0.07; p = 0.03) were also independently associated with worse LV GLS. E-selectin and ICAM-1 partially mediated the associations between higher body mass index and black race with worse GLS. Neither E-selectin nor ICAM-1 was associated with measures of LV diastolic function after multivariable adjustment.
CONCLUSION: Circulating levels of E-selectin and ICAM-1 and increases in ICAM-1 over the course of young adulthood are associated with worse indices of LV systolic function in midlife. These findings suggest associations of endothelial activation with subclinical HF with preserved ejection fraction.
Copyright © 2020 American College of Cardiology Foundation. All rights reserved.

Entities:  

Keywords:  cardiac mechanics; cellular adhesion molecules; heart failure with preserved ejection fraction; pathogenesis; subclinical

Mesh:

Substances:

Year:  2020        PMID: 32194198      PMCID: PMC7301611          DOI: 10.1016/j.jacc.2020.02.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

1.  Mediation Analysis.

Authors:  Hopin Lee; Robert D Herbert; James H McAuley
Journal:  JAMA       Date:  2019-02-19       Impact factor: 56.272

2.  Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.

Authors:  Anna L Beale; Shane Nanayakkara; Louise Segan; Justin A Mariani; Micha T Maeder; Vanessa van Empel; Donna Vizi; Shona Evans; Carolyn S P Lam; David M Kaye
Journal:  JACC Heart Fail       Date:  2019-03       Impact factor: 12.035

3.  Quality Control and Reproducibility in M-Mode, Two-Dimensional, and Speckle Tracking Echocardiography Acquisition and Analysis: The CARDIA Study, Year 25 Examination Experience.

Authors:  Anderson C Armstrong; Erin P Ricketts; Christopher Cox; Paul Adler; Alexander Arynchyn; Kiang Liu; Ellen Stengel; Stephen Sidney; Cora E Lewis; Pamela J Schreiner; James M Shikany; Kimberly Keck; Jamie Merlo; Samuel S Gidding; João A C Lima
Journal:  Echocardiography       Date:  2014-11-09       Impact factor: 1.724

4.  Impact of adiposity on cellular adhesion: The Multi-Ethnic Study of atherosclerosis (MESA).

Authors:  Mary J Christoph; Matthew A Allison; James S Pankow; Paul A Decker; Phillip S Kirsch; Michael Y Tsai; Michele M Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Cecilia Berardi; Christina L Wassel; Nicholas B Larson; Suzette J Bielinski
Journal:  Obesity (Silver Spring)       Date:  2015-12-06       Impact factor: 5.002

5.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

6.  Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.

Authors:  Sanjiv J Shah; Carolyn S P Lam; Sara Svedlund; Antti Saraste; Camilla Hage; Ru-San Tan; Lauren Beussink-Nelson; Ulrika Ljung Faxén; Maria Lagerström Fermer; Malin A Broberg; Li-Ming Gan; Lars H Lund
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

7.  Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN study.

Authors:  Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Laura Rasmussen-Torvik; Jin Sha; Marguerite R Irvin; C Charles Gu; Cora E Lewis; Steven C Hunt; Donna K Arnett; Sanjiv J Shah
Journal:  J Am Heart Assoc       Date:  2014-04-29       Impact factor: 5.501

8.  Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.

Authors:  Ane M Salvador; Tania Nevers; Francisco Velázquez; Mark Aronovitz; Bonnie Wang; Ana Abadía Molina; Iris Z Jaffe; Richard H Karas; Robert M Blanton; Pilar Alcaide
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

9.  Circulating Cellular Adhesion Molecules and Cognitive Function: The Coronary Artery Risk Development in Young Adults Study.

Authors:  Cynthia Yursun Yoon; Lyn M Steffen; Myron D Gross; Lenore J Launer; Andrew Odegaard; Alexander Reiner; Otto Sanchez; Kristine Yaffe; Stephen Sidney; David R Jacobs
Journal:  Front Cardiovasc Med       Date:  2017-05-24

10.  Where are they now? Retention strategies over 25 years in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Ellen Funkhouser; Jennifer Wammack; Cathy Roche; Jared Reis; Stephen Sidney; Pamela Schreiner
Journal:  Contemp Clin Trials Commun       Date:  2017-12-20
View more
  11 in total

1.  Insulin Resistance Is Associated with Right Ventricular Dysfunction.

Authors:  Jeff Min; Mary E Putt; Wei Yang; Nadine Al-Naamani; Alain G Bertoni; Joao A C Lima; R Graham Barr; Lauren Beussink-Nelson; Sanjiv J Shah; Steven M Kawut; Benjamin H Freed
Journal:  Ann Am Thorac Soc       Date:  2022-04

2.  Transcutaneous Vagus Nerve Stimulation Ameliorates the Phenotype of Heart Failure With Preserved Ejection Fraction Through Its Anti-Inflammatory Effects.

Authors:  Khaled Elkholey; Monika Niewiadomska; Lynsie Morris; Seabrook Whyte; Jeremy Houser; Mary Beth Humphrey; Stavros Stavrakis
Journal:  Circ Heart Fail       Date:  2022-07-07       Impact factor: 10.447

Review 3.  From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.

Authors:  Walter J Paulus; Michael R Zile
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

4.  HMGB1-Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice.

Authors:  Xin-Lin Zhang; Ting-Yu Wang; Zheng Chen; Hong-Wei Wang; Yong Yin; Lian Wang; Yong Wang; Biao Xu; Wei Xu
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

5.  Circulating Vascular Cell Adhesion Molecule-1 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Ravi B Patel; Laura A Colangelo; Suzette J Bielinski; Nicholas B Larson; Jingzhong Ding; Norrina B Allen; Erin D Michos; Sanjiv J Shah; Donald M Lloyd-Jones
Journal:  J Am Heart Assoc       Date:  2020-11-09       Impact factor: 5.501

6.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

Review 7.  The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction.

Authors:  Jerremy Weerts; Sanne G J Mourmans; Arantxa Barandiarán Aizpurua; Blanche L M Schroen; Christian Knackstedt; Etto Eringa; Alfons J H M Houben; Vanessa P M van Empel
Journal:  Biomolecules       Date:  2022-02-09

8.  Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis.

Authors:  Mingjun Zhu; Jingjing Wei; Ying Li; Yongxia Wang; Junguo Ren; Bin Li; Bo Ma; Xinlu Wang; Lijie Qiao; Cheng Zhou; Jianxun Liu
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

9.  Association of urine albumin-to-creatinine ratio with subclinical systolic dysfunction in hypertensive patients but not normotensive subjects: Danyang study.

Authors:  Ming Liu; Anxia He; Ye Wang; Chao Chen; Xixuan Zhao; Siqi Zhang; Junya Liang; Mulian Hua; Zhuyuan Fang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-10-21       Impact factor: 3.738

Review 10.  Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach.

Authors:  Antoni Bayes-Genis; Felipe Bisbal; Julio Núñez; Enrique Santas; Josep Lupón; Patrick Rossignol; Walter Paulus
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.